Florida Attorney General Pam Bondi announced Monday the state will be able to continue its Prescription Drug Monitoring Program—with some creative funding. The Legislature did not approve money for the drug program this session.
Bondi says the prescription drug monitoring database has been crucial in the state’s fight against "pill mills." Florida’s oxycodone death rate has fallen sharply over the past couple of years. And Bondi says she was surprised to see the Legislature adjourn this session without renewing funding for the program.